Sildenafil treatment is sufficient to boost cGMP/PKG actions via inhibiting PDE5 that has tremendous benefits to multiple cardiac diseases, including cardiac remodeling, myocardial infarction, DCM, and heart failure [55, 68–70]. The gene discussed is PRKG1; the disease is myocardial infarction.